All Stories

  1. ATRI LIMS: a cloud-native open-source laboratory information management system for biomarker-driven Alzheimer’s disease clinical trials

    Article • JAMIA Open, September 2026, Oxford University Press (OUP)

    Gustavo Jimenez-Maggiora

  2. More efficient screening for preclinical Alzheimer's clinical trials using mixture of experts

    Article • Alzheimer s & Dementia, September 2026, Wiley

    Gustavo Jimenez-Maggiora

  3. Normative Modeling of Brain Volume in Multiple Sclerosis Using Healthy Controls

    Article • Neurology Open Access, September 2026, Wolters Kluwer Health

    Gustavo Jimenez-Maggiora

  4. Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer’s disease

    Article • Translational Psychiatry, July 2026, Springer Science + Business Media

    Gustavo Jimenez-Maggiora

  5. Advancing open science in Alzheimer’s disease clinical trials: Sharing of A4 and LEARN neuroimaging data

    Article • Aperture Neuro, May 2026, Organization for Human Brain Mapping

    Gustavo Jimenez-Maggiora

  6. Remote outcome measures in Alzheimer's disease clinical trials: A call to action

    Article • The Journal of Prevention of Alzheimer s Disease, April 2026, Elsevier

    Gustavo Jimenez-Maggiora

  7. Alzheimer's clinical research data via R packages: The alzverse

    Article • Alzheimer s & Dementia, January 2026, Wiley

    Gustavo Jimenez-Maggiora

  8. Towards an AI biomedical scientist: Accelerating discoveries in neurodegenerative disease

    Article • The Journal of Prevention of Alzheimer s Disease, January 2026, Elsevier

    Gustavo Jimenez-Maggiora

  9. Integrating individualized connectome with amyloid pathology improves predictive modeling of future cognitive decline

    Article • Communications Medicine, December 2025, Springer Science + Business Media

    Gustavo Jimenez-Maggiora

  10. Estimation of reference curves for brain atrophy and analysis of robustness to machine effects

    Article • Scientific Reports, October 2025, Springer Science + Business Media

    Dr. Raymond Scott Turner, Professor of Clinical Psychiatry Adrian PREDA, Gustavo Jimenez-Maggiora

  11. Financial Incentives to Increase Diversity of Older Participants in a Memory Concerns Registry

    Article • JAMA Health Forum, August 2025, American Medical Association (AMA)

    Gustavo Jimenez-Maggiora

  12. Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials

    Article • The Journal of Prevention of Alzheimer s Disease, January 2025, Elsevier

    Gustavo Jimenez-Maggiora

  13. The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials

    Article • The Journal of Prevention of Alzheimer s Disease, October 2024, Elsevier

    Gustavo Jimenez-Maggiora, Dr. Raymond Scott Turner

  14. Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies

    Article • The Journal of Prevention of Alzheimer s Disease, August 2024, Elsevier

    Gustavo Jimenez-Maggiora

  15. Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer's Disease

    Article • The Journal of Prevention of Alzheimer s Disease, August 2024, Elsevier

    Gustavo Jimenez-Maggiora

  16. Maximizing the Utility of Alzheimer's Disease Trial Data: Sharing of Baseline A4 and LEARN Data

    Article • The Journal of Prevention of Alzheimer s Disease, August 2024, Elsevier

    Gustavo Jimenez-Maggiora

  17. Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial

    Article • Alzheimer s & Dementia, April 2024, Wiley

    Gustavo Jimenez-Maggiora

  18. Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease

    Article • Alzheimer s & Dementia, November 2023, Wiley

    Gustavo Jimenez-Maggiora

  19. Circular-SWAT for deep learning based diagnostic classification of Alzheimer's disease: application to metabolome data

    Article • EBioMedicine, November 2023, Elsevier

    Gustavo Jimenez-Maggiora

  20. Centralizing prescreening data collection to inform data-driven approaches to clinical trial recruitment

    Article • Alzheimer s Research & Therapy, May 2023, Springer Science + Business Media

    Gustavo Jimenez-Maggiora

  21. Improving community health‐care systems’ early detection of cognitive decline and dementia

    Article • Alzheimer s & Dementia, October 2022, Wiley

    Gustavo Jimenez-Maggiora

  22. Early-stage Alzheimer disease: getting trial-ready

    Article • Nature Reviews Neurology, April 2022, Springer Science + Business Media

    Gustavo Jimenez-Maggiora

  23. Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer’s disease

    Article • Nature Communications, March 2022, Springer Science + Business Media

    Professor of Clinical Psychiatry Adrian PREDA, Gustavo Jimenez-Maggiora

  24. ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials

    Article • JAMIA Open, January 2022, Oxford University Press (OUP)

    Gustavo Jimenez-Maggiora

  25. Corrigendum to: ATRI EDC: a novel cloud-native remote data capture system for large multicenter Alzheimer’s disease and Alzheimer’s disease-related dementias clinical trials

    Article • JAMIA Open, January 2022, Oxford University Press (OUP)

    Gustavo Jimenez-Maggiora

  26. Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status

    Article • Translational Psychiatry, November 2021, Springer Science + Business Media

    Gustavo Jimenez-Maggiora

  27. Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force

    Article • The Journal of Prevention of Alzheimer s Disease, October 2021, Elsevier

    Gustavo Jimenez-Maggiora

  28. Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study

    Article • Translational Psychiatry, September 2021, Springer Science + Business Media

    Gustavo Jimenez-Maggiora

  29. Predicting amyloid risk by machine learning algorithms based on the A4 screen data: Application to the Japanese Trial‐Ready Cohort study

    Article • Alzheimer s & Dementia Translational Research & Clinical Interventions, January 2021, Wiley

    Gustavo Jimenez-Maggiora

  30. Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials

    Article • The Journal of Prevention of Alzheimer s Disease, September 2020, Elsevier

    Gustavo Jimenez-Maggiora

  31. Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD)

    Article • The Journal of Prevention of Alzheimer s Disease, September 2020, Elsevier

    Gustavo Jimenez-Maggiora

  32. TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology

    Article • The Journal of Prevention of Alzheimer s Disease, September 2020, Elsevier

    Gustavo Jimenez-Maggiora

  33. The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer's Disease (TRC-PAD): Experience from the First 3 Years

    Article • The Journal of Prevention of Alzheimer s Disease, September 2020, Elsevier

    Gustavo Jimenez-Maggiora

  34. The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview

    Article • The Journal of Prevention of Alzheimer s Disease, September 2020, Elsevier

    Gustavo Jimenez-Maggiora

  35. World‐Wide FINGERS Network: A global approach to risk reduction and prevention of dementia

    Article • Alzheimer s & Dementia, July 2020, Wiley

    Gustavo Jimenez-Maggiora

  36. FAM222A encodes a protein which accumulates in plaques in Alzheimer’s disease

    Article • Nature Communications, January 2020, Springer Science + Business Media

    Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  37. A Novel Joint Brain Network Analysis Using Longitudinal Alzheimer’s Disease Data

    Article • Scientific Reports, December 2019, Springer Science + Business Media

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  38. Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification

    Article • Scientific Reports, September 2019, Springer Science + Business Media

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  39. Non-coding variability at the APOE locus contributes to the Alzheimer’s risk

    Article • Nature Communications, July 2019, Springer Science + Business Media

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  40. O4‐11‐03: U.S. POINTER: STUDY DESIGN AND LAUNCH

    Article • Alzheimer s & Dementia, July 2019, Wiley

    Gustavo Jimenez-Maggiora

  41. The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory

    Article • Nature Communications, April 2019, Springer Science + Business Media

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  42. White matter in different regions evolves differently during progression to dementia

    Article • Neurobiology of Aging, April 2019, Elsevier

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  43. Robust Motion Regression of Resting-State Data Using a Convolutional Neural Network Model

    Article • Frontiers in Neuroscience, February 2019, Frontiers

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  44. The Relationship Between Hippocampal Volumes and Delayed Recall Is Modified by APOE ε4 in Mild Cognitive Impairment

    Article • Frontiers in Aging Neuroscience, February 2019, Frontiers

    Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  45. A review of statistical methods in imaging genetics

    Article • Canadian Journal of Statistics, February 2019, Wiley

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  46. Diffusion MRI Indices and Their Relation to Cognitive Impairment in Brain Aging: The Updated Multi-protocol Approach in ADNI3

    Article • Frontiers in Neuroinformatics, February 2019, Frontiers

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  47. Longitudinal Brain Atrophy Rates in Transient Ischemic Attack and Minor Ischemic Stroke Patients and Cognitive Profiles

    Article • Frontiers in Neurology, February 2019, Frontiers

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  48. Predicting Short-term MCI-to-AD Progression Using Imaging, CSF, Genetic Factors, Cognitive Resilience, and Demographics

    Article • Scientific Reports, February 2019, Springer Science + Business Media

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  49. Random forest prediction of Alzheimer’s disease using pairwise selection from time series data

    Article • PLOS One, February 2019, PLOS

    Dr Paul J Moore, Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  50. Predicting Alzheimer’s disease progression using multi-modal deep learning approach

    Article • Scientific Reports, February 2019, Springer Science + Business Media

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  51. Translating Alzheimer's disease–associated polymorphisms into functional candidates: a survey of IGAP genes and SNPs

    Article • Neurobiology of Aging, February 2019, Elsevier

    Dr David W Fardo, Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  52. Amyloid beta–positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity

    Article • Neurobiology of Aging, February 2019, Elsevier

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  53. Association of CSF CD40 levels and synaptic degeneration across the Alzheimer’s disease spectrum

    Article • Neuroscience Letters, February 2019, Elsevier

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  54. Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling

    Article • NeuroImage, February 2019, Elsevier

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  55. Functional signature of conversion of patients with mild cognitive impairment

    Article • Neurobiology of Aging, February 2019, Elsevier

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  56. Medical Image Imputation From Image Collections

    Article • IEEE Transactions on Medical Imaging, February 2019, Institute of Electrical & Electronics Engineers (IEEE)

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  57. QuickNAT: A fully convolutional network for quick and accurate segmentation of neuroanatomy

    Article • NeuroImage, February 2019, Elsevier

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  58. MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders

    Article • Aging, January 2019, Impact Journals, LLC

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  59. Dual-Model Radiomic Biomarkers Predict Development of Mild Cognitive Impairment Progression to Alzheimer’s Disease

    Article • Frontiers in Neuroscience, January 2019, Frontiers

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  60. A δ Homolog for Dementia Case Finding with Replication in the Alzheimer’s Disease Neuroimaging Initiative

    Article • Journal of Alzheimer’s Disease, January 2019, IOS Press

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  61. Next Generation Sequencing Analysis in Early Onset Dementia Patients

    Article • Journal of Alzheimer’s Disease, January 2019, IOS Press

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  62. A concise and persistent feature to study brain resting‐state network dynamics: Findings from the Alzheimer's Disease Neuroimaging Initiative

    Article • Human Brain Mapping, December 2018, Wiley

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  63. Accurate risk estimation of β‐amyloid positivity to identify prodromal Alzheimer's disease: Cross‐validation study of practical algorithms

    Article • Alzheimer s & Dementia, October 2018, Wiley

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  64. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome

    Article • Alzheimer s & Dementia, October 2018, Wiley

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  65. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers

    Article • Alzheimer s & Dementia, October 2018, Wiley

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  66. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative

    Article • Alzheimer s & Dementia, October 2018, Wiley

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  67. A Novel Method to Estimate Long‐Term Chronological Changes From Fragmented Observations in Disease Progression

    Article • Clinical Pharmacology & Therapeutics, August 2018, Wiley

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  68. P1‐345: CLASSIFICATION OF EMOTIONAL RESPONSES IN VIDEO AND AUDIO RECORDINGS USING A CONVOLUTIONAL NEURAL NETWORK

    Article • Alzheimer s & Dementia, July 2018, Wiley

    Gustavo Jimenez-Maggiora

  69. P2‐571: A STEP FORWARD IN INTEGRATING HEALTHCARE AND VOICE‐ENABLED TECHNOLOGY: CONCEPT DEMONSTRATION WITH DEPLOYMENT OF AUTOMATIC MEDICAL CODING MODEL AS AN AMAZON “ALEXA” SKILL

    Article • Alzheimer s & Dementia, July 2018, Wiley

    Gustavo Jimenez-Maggiora

  70. P3‐014: DEEP LEARNING IN AUTOMATED CLASSIFICATION OF ADVERSE EVENTS IN CLINICAL STUDIES OF ALZHEIMER'S DISEASE

    Article • Alzheimer s & Dementia, July 2018, Wiley

    Gustavo Jimenez-Maggiora

  71. TD‐P‐016: DEEP LEARNING IN AUTOMATED CLASSIFICATION OF ADVERSE EVENTS IN CLINICAL STUDIES OF ALZHEIMER'S DISEASE

    Article • Alzheimer s & Dementia, July 2018, Wiley

    Gustavo Jimenez-Maggiora

  72. Communicability disruption in Alzheimer’s disease connectivity networks

    Article • Journal of Complex Networks, May 2018, Oxford University Press (OUP)

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  73. Biomedical informatics applications for precision management of neurodegenerative diseases

    Article • Alzheimer s & Dementia Translational Research & Clinical Interventions, January 2018, Wiley

    Gustavo Jimenez-Maggiora

  74. Longitudinal Functional Brain Mapping in Supernormals

    Article • Cerebral Cortex, November 2017, Oxford University Press (OUP)

    Professor of Clinical Psychiatry Adrian PREDA, Dr. Raymond Scott Turner, Gustavo Jimenez-Maggiora

  75. [P4–007]: MACHINE LEARNING IN AUTOMATED CLASSIFICATION OF ADVERSE EVENTS IN CLINICAL STUDIES OF ALZHEIMER's DISEASE

    Article • Alzheimer s & Dementia, July 2017, Wiley

    Gustavo Jimenez-Maggiora

  76. Exploratory Clustering for Patient Subpopulation Discovery

    Article • January 2017, IOS Press

    Dr. Raymond Scott Turner, Professor of Clinical Psychiatry Adrian PREDA, Gustavo Jimenez-Maggiora

  77. Results of the ICTuS 2 Trial (Intravascular Cooling in the Treatment of Stroke 2)

    Article • Stroke, December 2016, Wolters Kluwer Health

    Gustavo Jimenez-Maggiora

  78. Randomized Controlled Trial of an Internet Application to Reduce HIV Transmission Behavior Among HIV Infected Men Who have Sex with Men

    Article • AIDS and Behavior, October 2015, Springer Science + Business Media

    Gustavo Jimenez-Maggiora

  79. P1‐357: ADCS EDC: INVESTIGATIONAL PRODUCT MANAGEMENT SYSTEM

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Gustavo Jimenez-Maggiora

  80. P1‐358: ADCS EDC: DATA EXCHANGE AND PROCESSING PLATFORM

    Article • Alzheimer s & Dementia, July 2014, Wiley

    Gustavo Jimenez-Maggiora

  81. P4–184: ADCS electronic data capture: Integrated image management

    Article • Alzheimer s & Dementia, July 2013, Wiley

    Gustavo Jimenez-Maggiora

  82. P4–157: Adcs electronic data capture: Collaborative development and management of clinical trial databases

    Article • Alzheimer s & Dementia, July 2013, Wiley

    Gustavo Jimenez-Maggiora

  83. P3‐364: ADCS EDC

    Article • Alzheimer s & Dementia, July 2012, Wiley

    Gustavo Jimenez-Maggiora

  84. P3‐383: ADCS data sharing

    Article • Alzheimer s & Dementia, July 2012, Wiley

    Gustavo Jimenez-Maggiora